Global Point-of-care Infectious Disease Diagnostics Market Research Report 2023

Report ID: 1992265 | Published Date: Oct 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 HIV POC
        1.2.3 Clostridium Difficile POC
        1.2.4 HBV POC
        1.2.5 Respiratory Syncytial Virus POC
        1.2.6 HPV POC
        1.2.7 Influenza/Flu POC
        1.2.8 HCV POC
        1.2.9 MRSA POC
        1.2.10 TB and Drug-Resistant TB POC
    1.3 Market by Application
        1.3.1 Global Point-of-care Infectious Disease Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Home
        1.3.5 Assisted Living Healthcare Facilities
        1.3.6 Laboratories
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2018-2029)
    2.2 Point-of-care Infectious Disease Diagnostics Growth Trends by Region
        2.2.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Size by Region (2018-2023)
        2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2029)
    2.3 Point-of-care Infectious Disease Diagnostics Market Dynamics
        2.3.1 Point-of-care Infectious Disease Diagnostics Industry Trends
        2.3.2 Point-of-care Infectious Disease Diagnostics Market Drivers
        2.3.3 Point-of-care Infectious Disease Diagnostics Market Challenges
        2.3.4 Point-of-care Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue
        3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2018-2023)
        3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2018-2023)
    3.2 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue
    3.4 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio
        3.4.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2022
    3.5 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served
    3.6 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
    3.7 Date of Enter into Point-of-care Infectious Disease Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Infectious Disease Diagnostics Breakdown Data by Type
    4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2018-2023)
    4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2029)
5 Point-of-care Infectious Disease Diagnostics Breakdown Data by Application
    5.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Application (2018-2023)
    5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
    6.2 North America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023)
    6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
    7.2 Europe Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023)
    7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
    8.2 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2018-2023)
    8.4 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
    9.2 Latin America Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023)
    9.4 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
    10.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023)
    10.4 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Detail
        11.1.2 Thermo Fisher Scientific Business Overview
        11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction
        11.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.1.5 Thermo Fisher Scientific Recent Development
    11.2 Abbott
        11.2.1 Abbott Company Detail
        11.2.2 Abbott Business Overview
        11.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction
        11.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.2.5 Abbott Recent Development
    11.3 Calypte Biomedical
        11.3.1 Calypte Biomedical Company Detail
        11.3.2 Calypte Biomedical Business Overview
        11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction
        11.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.3.5 Calypte Biomedical Recent Development
    11.4 Chembio Diagnostic Systems
        11.4.1 Chembio Diagnostic Systems Company Detail
        11.4.2 Chembio Diagnostic Systems Business Overview
        11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction
        11.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.4.5 Chembio Diagnostic Systems Recent Development
    11.5 Meridian Bioscience
        11.5.1 Meridian Bioscience Company Detail
        11.5.2 Meridian Bioscience Business Overview
        11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction
        11.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.5.5 Meridian Bioscience Recent Development
    11.6 MedMira
        11.6.1 MedMira Company Detail
        11.6.2 MedMira Business Overview
        11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction
        11.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.6.5 MedMira Recent Development
    11.7 Trinity Biotech
        11.7.1 Trinity Biotech Company Detail
        11.7.2 Trinity Biotech Business Overview
        11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction
        11.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.7.5 Trinity Biotech Recent Development
    11.8 Sekisui Diagnostics
        11.8.1 Sekisui Diagnostics Company Detail
        11.8.2 Sekisui Diagnostics Business Overview
        11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction
        11.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.8.5 Sekisui Diagnostics Recent Development
    11.9 OraSure Technologies
        11.9.1 OraSure Technologies Company Detail
        11.9.2 OraSure Technologies Business Overview
        11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction
        11.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.9.5 OraSure Technologies Recent Development
    11.10 Quidel
        11.10.1 Quidel Company Detail
        11.10.2 Quidel Business Overview
        11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction
        11.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
        11.10.5 Quidel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of HIV POC
    Table 3. Key Players of Clostridium Difficile POC
    Table 4. Key Players of HBV POC
    Table 5. Key Players of Respiratory Syncytial Virus POC
    Table 6. Key Players of HPV POC
    Table 7. Key Players of Influenza/Flu POC
    Table 8. Key Players of HCV POC
    Table 9. Key Players of MRSA POC
    Table 10. Key Players of TB and Drug-Resistant TB POC
    Table 11. Global Point-of-care Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 12. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 13. Global Point-of-care Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
    Table 14. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2018-2023)
    Table 15. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 16. Global Point-of-care Infectious Disease Diagnostics Market Share by Region (2024-2029)
    Table 17. Point-of-care Infectious Disease Diagnostics Market Trends
    Table 18. Point-of-care Infectious Disease Diagnostics Market Drivers
    Table 19. Point-of-care Infectious Disease Diagnostics Market Challenges
    Table 20. Point-of-care Infectious Disease Diagnostics Market Restraints
    Table 21. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2018-2023) & (US$ Million)
    Table 22. Global Point-of-care Infectious Disease Diagnostics Market Share by Players (2018-2023)
    Table 23. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2022)
    Table 24. Ranking of Global Top Point-of-care Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2022
    Table 25. Global 5 Largest Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2018-2023)
    Table 26. Key Players Headquarters and Area Served
    Table 27. Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
    Table 28. Date of Enter into Point-of-care Infectious Disease Diagnostics Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2018-2023) & (US$ Million)
    Table 31. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2018-2023)
    Table 32. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 33. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2024-2029)
    Table 34. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2018-2023) & (US$ Million)
    Table 35. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2018-2023)
    Table 36. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 37. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Application (2024-2029)
    Table 38. North America Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 40. North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Europe Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2018-2023) & (US$ Million)
    Table 46. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2024-2029) & (US$ Million)
    Table 47. Latin America Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 50. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 51. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 52. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 53. Thermo Fisher Scientific Company Detail
    Table 54. Thermo Fisher Scientific Business Overview
    Table 55. Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Product
    Table 56. Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 57. Thermo Fisher Scientific Recent Development
    Table 58. Abbott Company Detail
    Table 59. Abbott Business Overview
    Table 60. Abbott Point-of-care Infectious Disease Diagnostics Product
    Table 61. Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 62. Abbott Recent Development
    Table 63. Calypte Biomedical Company Detail
    Table 64. Calypte Biomedical Business Overview
    Table 65. Calypte Biomedical Point-of-care Infectious Disease Diagnostics Product
    Table 66. Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 67. Calypte Biomedical Recent Development
    Table 68. Chembio Diagnostic Systems Company Detail
    Table 69. Chembio Diagnostic Systems Business Overview
    Table 70. Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Product
    Table 71. Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 72. Chembio Diagnostic Systems Recent Development
    Table 73. Meridian Bioscience Company Detail
    Table 74. Meridian Bioscience Business Overview
    Table 75. Meridian Bioscience Point-of-care Infectious Disease Diagnostics Product
    Table 76. Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 77. Meridian Bioscience Recent Development
    Table 78. MedMira Company Detail
    Table 79. MedMira Business Overview
    Table 80. MedMira Point-of-care Infectious Disease Diagnostics Product
    Table 81. MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 82. MedMira Recent Development
    Table 83. Trinity Biotech Company Detail
    Table 84. Trinity Biotech Business Overview
    Table 85. Trinity Biotech Point-of-care Infectious Disease Diagnostics Product
    Table 86. Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 87. Trinity Biotech Recent Development
    Table 88. Sekisui Diagnostics Company Detail
    Table 89. Sekisui Diagnostics Business Overview
    Table 90. Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Product
    Table 91. Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 92. Sekisui Diagnostics Recent Development
    Table 93. OraSure Technologies Company Detail
    Table 94. OraSure Technologies Business Overview
    Table 95. OraSure Technologies Point-of-care Infectious Disease Diagnostics Product
    Table 96. OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 97. OraSure Technologies Recent Development
    Table 98. Quidel Company Detail
    Table 99. Quidel Business Overview
    Table 100. Quidel Point-of-care Infectious Disease Diagnostics Product
    Table 101. Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2018-2023) & (US$ Million)
    Table 102. Quidel Recent Development
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Point-of-care Infectious Disease Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Point-of-care Infectious Disease Diagnostics Market Share by Type: 2022 VS 2029
    Figure 3. HIV POC Features
    Figure 4. Clostridium Difficile POC Features
    Figure 5. HBV POC Features
    Figure 6. Respiratory Syncytial Virus POC Features
    Figure 7. HPV POC Features
    Figure 8. Influenza/Flu POC Features
    Figure 9. HCV POC Features
    Figure 10. MRSA POC Features
    Figure 11. TB and Drug-Resistant TB POC Features
    Figure 12. Global Point-of-care Infectious Disease Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 13. Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2022 VS 2029
    Figure 14. Hospitals Case Studies
    Figure 15. Clinics Case Studies
    Figure 16. Home Case Studies
    Figure 17. Assisted Living Healthcare Facilities Case Studies
    Figure 18. Laboratories Case Studies
    Figure 19. Others Case Studies
    Figure 20. Point-of-care Infectious Disease Diagnostics Report Years Considered
    Figure 21. Global Point-of-care Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 22. Global Point-of-care Infectious Disease Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 23. Global Point-of-care Infectious Disease Diagnostics Market Share by Region: 2022 VS 2029
    Figure 24. Global Point-of-care Infectious Disease Diagnostics Market Share by Players in 2022
    Figure 25. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2022)
    Figure 26. The Top 10 and 5 Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue in 2022
    Figure 27. North America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. North America Point-of-care Infectious Disease Diagnostics Market Share by Country (2018-2029)
    Figure 29. United States Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Canada Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Europe Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Europe Point-of-care Infectious Disease Diagnostics Market Share by Country (2018-2029)
    Figure 33. Germany Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. France Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. U.K. Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Italy Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Russia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Nordic Countries Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Share by Region (2018-2029)
    Figure 41. China Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Japan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. South Korea Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. India Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Australia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Latin America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Latin America Point-of-care Infectious Disease Diagnostics Market Share by Country (2018-2029)
    Figure 49. Mexico Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 50. Brazil Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Share by Country (2018-2029)
    Figure 53. Turkey Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 56. Abbott Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 57. Calypte Biomedical Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 58. Chembio Diagnostic Systems Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 59. Meridian Bioscience Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 60. MedMira Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 61. Trinity Biotech Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 62. Sekisui Diagnostics Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 63. OraSure Technologies Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 64. Quidel Revenue Growth Rate in Point-of-care Infectious Disease Diagnostics Business (2018-2023)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific
Abbott
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Quidel
Frequently Asked Questions
Point-of-care Infectious Disease Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Point-of-care Infectious Disease Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Point-of-care Infectious Disease Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Polyamideimide

This report aims to provide a comprehensive presentation of the global market for Polyamideimide, ... Read More